The legal action stems from a report by short seller Hunterbrook, which concluded a five-month investigation into the company’s operations. The report alleges that Ensign Group’s profitability is tied to chronic understaffing and the redirection of taxpayer funds toward executives and affiliates. Most critically, the investigation claims these practices have led to instances of patient suffering and preventable deaths.

Shareholders who acquired Ensign securities are now being evaluated for potential class action participation. Rosen Law Firm, led by founding partner Laurence Rosen, is managing the outreach to affected investors, emphasizing a contingency-based recovery model. Investors seeking to participate can contact Phillip Kim at 866-767-3653 or register via the firm’s online portal.